Page last updated: 2024-09-03

glycyl-arginyl-glycyl-aspartyl-serine and Urinary Bladder Neoplasms

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Urinary Bladder Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gordon, CS; Hyacinthe, LM; Jarrett, TW; Vaughan, ED; Whalen, GF1
Ardelt, P; Böhle, A; Brandau, S; Jocham, D; Jurczok, A; Ulmer, AJ; Wulf, T1

Other Studies

2 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Urinary Bladder Neoplasms

ArticleYear
Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS).
    Annals of surgical oncology, 1995, Volume: 2, Issue:5

    Topics: Animals; Antineoplastic Agents; Cautery; Cell Adhesion; Epithelium; Extracellular Matrix; Female; Heparin; Mannose; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Oligopeptides; Urinary Bladder; Urinary Bladder Neoplasms; Wound Healing

1995
Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo.
    The Journal of urology, 2002, Volume: 167, Issue:1

    Topics: Animals; Cell Adhesion; Cell Line; Collagen Type I; Female; Fibronectins; Humans; Laminin; Mice; Mice, Inbred C57BL; Oligopeptides; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002